Skip to main content
Premium Trial:

Request an Annual Quote

Athanasios Maroglou, Len van Zyl, Dile Holton, Steve Bolze


Athanasios Maroglou, president and chief operating officer of Ercole Biotech of Research Triangle Park, NC, has joined the board of directors for Array Xpress, the Raleigh, NC-based microarray services startup spinning out of North Carolina State University to commercialize microarray technology developed by Len van Zyl, an assistant professor in the school's forest biotechnology group. Maroglou is also president of Thalima, a life science venture development company. Previously, he was vice president of project management for RTP-based Paradigm Genetics. He holds a PhD and a BSc in chemical engineering from the University of Birmingham, UK.

Dile Holton has joined MicroCal of Northampton, Mass., as marketing manager. Previously, Holton was a product manager for PerkinElmer Life and Analytical Sciences and involved in industry microarray standardization efforts.

Steve Bolze, 40, has been named General Electric’s vice president for Amersham integration planning. Bolze joined GE Medical Systems in 2002 as general manager, global functional and molecular imaging. Previously, Steve held several roles within GE Power Systems. Bolze joined GE in 1993. He holds a BS in electrical engineering from Duke University, and an MBA from the University of Michigan.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.